retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Eli Lilly's Phase 3 data
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
























